Amélie Barczyk

Inhibition of tumor cell growth and angiogenesis by 7-Aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors

Séverine Ravez, Amélie Barczyk, Perrine Six et al. · European Journal of Medicinal Chemistry · 2014 · 34 citations

Medicine, Medicinal Chemistry, Oncology +16

Synthesis of triazoloquinazolinone based compounds as tubulin polymerization inhibitors and vascular disrupting agents

Mohsine Driowya, Julien Leclercq, Valérie Verones et al. · European Journal of Medicinal Chemistry · 2016 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Conformational Restriction Leading to a Selective CB₂ Cannabinoid Receptor Agonist Orally Active Against Colitis

Jamal El Bakali, Giulio G. Muccioli, Mathilde Body–Malapel et al. · ACS Medicinal Chemistry Letters · 2014 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

4-Oxo-1,4-dihydropyridines as Selective CB₂ Cannabinoid Receptor Ligands Part 2: Discovery of New Agonists Endowed with Protective Effect Against Experimental Colitis

Jamal El Bakali, Pauline Gilleron, Mathilde Body–Malapel et al. · Journal of Medicinal Chemistry · 2012 · 24 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Synthesis and Biological Evaluation of <i>N</i>-[2-(4-Hydroxyphenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide (ABT-751) Tricyclic Analogues as Antimitotic and Antivascular Agents with Potent in Vivo Antitumor Activity

Zacharie Segaoula, Julien Leclercq, Valérie Verones et al. · Journal of Medicinal Chemistry · 2016 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14